WEBULL
WebtradeDownload

Kenneth Samet Bought 94% More Shares In AdaptHealth

Simply Wall St · 1d ago

Investors who take an interest in AdaptHealth Corp. (NASDAQ:AHCO) should definitely note that the Independent Director, Kenneth Samet, recently paid US$6.38 per share to buy US$150k worth of the stock. That certainly has us anticipating the best, especially since they thusly increased their own holding by 94%, potentially signalling some real optimism.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

AdaptHealth Insider Transactions Over The Last Year

In fact, the recent purchase by Kenneth Samet was the biggest purchase of AdaptHealth shares made by an insider individual in the last twelve months, according to our records. That means that even when the share price was higher than US$5.65 (the recent price), an insider wanted to purchase shares. It's very possible they regret the purchase, but it's more likely they are bullish about the company. In our view, the price an insider pays for shares is very important. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.

Happily, we note that in the last year insiders paid US$511k for 76.50k shares. On the other hand they divested 13.20k shares, for US$127k. In the last twelve months there was more buying than selling by AdaptHealth insiders. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

See our latest analysis for AdaptHealth

insider-trading-volume
NasdaqCM:AHCO Insider Trading Volume August 12th 2026

AdaptHealth is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of AdaptHealth

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 8.4% of AdaptHealth shares, worth about US$58m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The AdaptHealth Insider Transactions Indicate?

The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Insiders likely see value in AdaptHealth shares, given these transactions (along with notable insider ownership of the company). So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. In terms of investment risks, we've identified 1 warning sign with AdaptHealth and understanding it should be part of your investment process.

But note: AdaptHealth may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.